Immuron engages LifeSci Capital to explore strategic initiatives

IMRN•2026-11-10

Immuron engaged LifeSci Capital as its exclusive financial advisor to explore strategic initiatives, which may include mergers, acquisitions, licensing or other transactions.

1. Potential transactions

Immuron engaged LifeSci Capital as its exclusive financial advisor to explore strategic initiatives, including possible mergers, acquisitions, licensing or other transactions.

Immuron engages LifeSci Capital to explore strategic initiatives

1. Potential transactions

Related News

BioNTech to buy FDA priority review voucher from Scholar Rock for $205 million

Nvidia CEO's affair with alleged spy reportedly aided $7.5 billion in China chip shipments

Cullinan Therapeutics Q3 net loss narrows to $49.4 million

Kustom Entertainment swings to Q3 net income of $2.35 million

Enova board authorizes $500 million share repurchase program